McInerney and Plotsker join Emisphere board
This article was originally published in Scrip
Emisphere Technologies, a biopharma that focuses on unique and improved drug delivery, has appointed Tim McInerney and Jacob Plotsker to its board of directors. Mr McInerney is currently a partner with Riverbank Capital Securities, an investment banking firm specialising in financing for biotech and specialty pharma companies. Mr Plotsker is senior director of commercial operations for Teva Pharmaceuticals' Women's Health division.